• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素会增加功能性腹部症状。

Antibiotics increase functional abdominal symptoms.

作者信息

Maxwell P R, Rink E, Kumar D, Mendall M A

机构信息

Department of General Practice and Primary Care, St George's Hospital Medical School, London, United Kingdom.

出版信息

Am J Gastroenterol. 2002 Jan;97(1):104-8. doi: 10.1111/j.1572-0241.2002.05428.x.

DOI:10.1111/j.1572-0241.2002.05428.x
PMID:11808932
Abstract

OBJECTIVES

Data suggest that subjects with irritable bowel syndrome are more likely to report a recent course of antibiotics. This study tests the hypothesis that a course of antibiotics is a risk factor for an increase in the number of functional bowel complaints over a 4-month period in a general population sample.

METHODS

We initiated a prospective case-control study in three general practices in South London. Consecutive patients aged 16-49 attending their general practitioner with non-GI complaints and given a prescription for antibiotics were invited to participate. Comparison subjects who had not had antibiotics for 1 yr were identified from the practice records by age group, gender, and previous general practitioner visits. Fifty-eight antibiotic and 65 control patients agreed to participate. Questionnaires covering demographic, GI, and psychological data were sent at recruitment and at 4 months. Seventy-four percent of subjects completed the study. The number of symptoms at follow-up compared to that at recruitment.

RESULTS

Twenty of 42 antibiotic subjects (48%) versus 11/49 control subjects (22%) demonstrated one or more additional functional bowel symptoms at 4 months (unadjusted odds ratio = 3.14 [1.27-7.75]) (chi2 = 6.4, p = 0.01). Ten of 42 antibiotic subjects (24%) versus 3/49 control subjects (6%) demonstrated two or more additional functional bowel symptoms at 4 months (unadjusted odds ratio = 4.79 [1.22-18.80]) (chi2 = 5.8, p = 0.02).

CONCLUSIONS

Functional bowel symptoms come and go, but subjects who are given a course of antibiotics are more than three times as likely to report more bowel symptoms 4 months later than controls.

摘要

目的

数据表明,肠易激综合征患者更有可能报告近期使用过抗生素疗程。本研究检验了这样一个假设:在普通人群样本中,抗生素疗程是4个月内功能性肠道不适数量增加的一个风险因素。

方法

我们在伦敦南部的三个全科诊所开展了一项前瞻性病例对照研究。邀请连续16 - 49岁因非胃肠道疾病就诊于全科医生并开具抗生素处方的患者参与。通过年龄组、性别和之前的全科医生就诊记录,从诊所记录中识别出过去1年未使用过抗生素的对照受试者。58名使用抗生素的患者和65名对照患者同意参与。在招募时和4个月时发送涵盖人口统计学、胃肠道和心理数据的问卷。74%的受试者完成了研究。将随访时的症状数量与招募时的症状数量进行比较。

结果

42名使用抗生素的受试者中有20名(48%)在4个月时出现了一种或多种额外的功能性肠道症状,而49名对照受试者中有11名(22%)出现了这种情况(未调整优势比 = 3.14 [1.27 - 7.75])(χ² = 6.4,p = 0.01)。42名使用抗生素的受试者中有10名(24%)在4个月时出现了两种或更多额外的功能性肠道症状,而49名对照受试者中有3名(6%)出现了这种情况(未调整优势比 = 4.79 [1.22 - 18.80])(χ² = 5.8,p = 0.02)。

结论

功能性肠道症状时有时无,但接受抗生素疗程的受试者在4个月后报告肠道症状增多的可能性是对照组的三倍多。

相似文献

1
Antibiotics increase functional abdominal symptoms.抗生素会增加功能性腹部症状。
Am J Gastroenterol. 2002 Jan;97(1):104-8. doi: 10.1111/j.1572-0241.2002.05428.x.
2
Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.全科医疗中细菌性肠胃炎发作后肠易激综合征的风险:合并症的影响
Clin Gastroenterol Hepatol. 2007 Apr;5(4):465-9. doi: 10.1016/j.cgh.2007.02.008.
3
Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study.肠易激综合征在细菌性肠胃炎患者中更常见吗?一项基于社区的病例对照研究。
Am J Gastroenterol. 2003 Feb;98(2):327-31. doi: 10.1111/j.1572-0241.2003.07242.x.
4
Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study.心理困扰是否会调节功能性胃肠道症状及医疗求助行为?一项前瞻性社区队列研究。
Am J Gastroenterol. 2003 Apr;98(4):789-97. doi: 10.1111/j.1572-0241.2003.07388.x.
5
Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults.感染性腹泻后的胃肠道症状:瑞典成年人群体的五年随访
Clin Gastroenterol Hepatol. 2007 Apr;5(4):461-4. doi: 10.1016/j.cgh.2007.01.007.
6
High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study.采用无麸质饮食的腹腔疾病患者胃肠道症状发生率高:对照研究。
Am J Gastroenterol. 2003 Sep;98(9):2023-6. doi: 10.1111/j.1572-0241.2003.07632.x.
7
Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.前往墨西哥的北美旅行者腹泻后慢性肠道症状和肠易激综合征
Am J Gastroenterol. 2004 Sep;99(9):1774-8. doi: 10.1111/j.1572-0241.2004.30435.x.
8
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.便秘型或腹泻型肠易激综合征患者的上、下消化道症状重叠。
Am J Gastroenterol. 2003 Nov;98(11):2454-9. doi: 10.1111/j.1572-0241.2003.07699.x.
9
Diet and functional gastrointestinal disorders: a population-based case-control study.饮食与功能性胃肠疾病:一项基于人群的病例对照研究。
Am J Gastroenterol. 2005 Dec;100(12):2743-8. doi: 10.1111/j.1572-0241.2005.00288.x.
10
The value of a general therapeutic approach in subjects with irritable bowel syndrome.
Aliment Pharmacol Ther. 2005 Jan 1;21(1):21-7. doi: 10.1111/j.1365-2036.2004.02302.x.

引用本文的文献

1
The gut microbiome in disorders of gut-brain interaction.肠-脑相互作用障碍中的肠道微生物组。
Gut Microbes. 2024 Jan-Dec;16(1):2360233. doi: 10.1080/19490976.2024.2360233. Epub 2024 Jul 1.
2
Gut microbiota signatures and modulation in irritable bowel syndrome.肠易激综合征中的肠道微生物群特征与调节
Microbiome Res Rep. 2022 Mar 5;1(2):11. doi: 10.20517/mrr.2021.12. eCollection 2022.
3
Early life adverse exposures in irritable bowel syndrome: new insights and opportunities.肠易激综合征的早期不良暴露:新见解与机遇
Front Pediatr. 2023 Sep 5;11:1241801. doi: 10.3389/fped.2023.1241801. eCollection 2023.
4
Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota.粪便 β-防御素-3 分泌的改变作为肠道微生物组不稳定的标志物。
Gut Microbes. 2023 Jan-Dec;15(1):2233679. doi: 10.1080/19490976.2023.2233679.
5
Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank.肠易激综合征相关因素及各亚型之间的差异:英国生物银行的一项横断面研究
Front Pharmacol. 2022 Aug 26;13:905564. doi: 10.3389/fphar.2022.905564. eCollection 2022.
6
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.痛泻要方治疗腹泻型肠易激综合征的随机、双盲、安慰剂对照临床试验方案
Trials. 2022 Mar 21;23(1):226. doi: 10.1186/s13063-022-06142-x.
7
Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders.抗生素的使用而非胃肠道感染常先于功能性胃肠道疾病的首次诊断。
United European Gastroenterol J. 2021 Nov;9(9):1074-1080. doi: 10.1002/ueg2.12164. Epub 2021 Oct 15.
8
Exploring Quality of Life, Stress, and Risk Factors Associated with Irritable Bowel Syndrome for Female University Students in Taiwan.探讨台湾地区女大学生肠易激综合征的生活质量、压力和相关风险因素。
Int J Environ Res Public Health. 2021 Apr 7;18(8):3888. doi: 10.3390/ijerph18083888.
9
Clinical Management of the Microbiome in Irritable Bowel Syndrome.肠易激综合征中微生物群的临床管理
J Can Assoc Gastroenterol. 2020 Jan 4;4(1):36-43. doi: 10.1093/jcag/gwz037. eCollection 2021 Feb.
10
Role of Inflammation in Pathophysiology of Colonic Disease: An Update.炎症在结肠疾病发病机制中的作用:最新进展。
Int J Mol Sci. 2020 Jul 3;21(13):4748. doi: 10.3390/ijms21134748.